Changes in the redox status of the brain in an experimental glaucoma model

The purpose of this study was to evaluate the redox status changes of primary visual targets in the rat brain of a high pressure-induced glaucoma model. The animal model consisted of inducing ocular hypertension by cauterizing two episcleral veins on the left eye. The markers of oxidative damage and...

Full description

Saved in:
Bibliographic Details
Published in:Biocell 2016, Vol.40 (1), p.51-54
Main Authors: G. REIDES, Claudia, M. LASAGNI VITAR, Romina, PEVERINI, Agustina, S. JANEZIC, Natasha, G. HVOZDA ARANA, Ailen, M. FERREIRA, Sandra, F. LLESUY, Susana
Format: Article
Language:English
Subjects:
Animal models
Antioxidants
Glaucoma
Glutathione peroxidase
Glutathione reductase
NAD(P)H oxidase
Neurodegeneration
Nitrites
Optic nerve
Oxidative stress
Retina
Risk factors
Superoxide dismutase
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this study was to evaluate the redox status changes of primary visual targets in the rat brain of a high pressure-induced glaucoma model. The animal model consisted of inducing ocular hypertension by cauterizing two episcleral veins on the left eye. The markers of oxidative damage and the oxidative balance evaluated in the brain seven days postoperative were: nitrites concentration, levels of non-enzymatic antioxidants and antioxidant enzymes activity. The increase in the nitrite content, which could be the result of the enhancement in the production of nitrogen species, and in the activity of NADPH oxidase in the glaucoma group could lead to an increase on lipid and protein damage. The decrease on the non-enzymatic antioxidants and the compensatory increase of the superoxide dismutase and glutathione peroxidase activities could be a consequence of the increase of oxidative processes. The decrease in the activity of glutathione reductase leads to a decrease in the recycling of thiol groups. We suggest that oxidative stress can possibly acts as a risk factor for neurodegeneration in the brain. Therapeutic strategies to stop the progression of the disease in glaucoma should also be considered the central neuronal degeneration beyond the retina and the optic nerve.
ISSN:1667-5746
0327-9545
DOI:10.32604/biocell.2016.40.051